Skip to main content
Watch Insiders
Market intelligence
VRDNHealthcare

Viridian Therapeutics Inc insider activity

In the last 90 days, 3 corporate insiders purchased $59,999,970 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$59,999,970
Corporate buyers
3
Latest transaction
May 11, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 11, 2026Fairmount Healthcare Fund Ii L.p.Corporate insiderOpen Market Purchase1,176,470$17.00$19,999,990
May 11, 2026Fairmount Funds Management LlcCorporate insiderOpen Market Purchase1,176,470$17.00$19,999,990
May 11, 2026Fairmount Healthcare Fund Ii Gp LlcCorporate insiderOpen Market Purchase1,176,470$17.00$19,999,990